We are live on
!
Find out more
AA
AlphaMark Advisors Portfolio holdings
AUM
$231M
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$168M
AUM Growth
+$5.28M
(+3.3%)
Cap. Flow
-$1.1M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
28.41%
Holding
314
New
29
Increased
45
Reduced
71
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.64M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$788K |
| 3 |
Universal Electronics
UEIC
|
+$598K |
| 4 |
ASRT
Assertio
ASRT
|
+$584K |
| 5 |
TAL Education Group
TAL
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$3.81M |
| 2 |
Vaalco Energy
EGY
|
+$945K |
| 3 |
The Ensign Group
ENSG
|
+$787K |
| 4 |
PVH
PVH
|
+$693K |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$674K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.79% |
| 2 | Healthcare | 16.33% |
| 3 | Industrials | 9.84% |
| 4 | Consumer Discretionary | 8.38% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
301
The Ensign Group
ENSG
$10.4B
| – | – |
-70,718
| Closed | -$787K |
|
302
iShares MSCI Japan ETF
EWJ
$21.9B
| – | – |
-24
| Closed | -$15K |
|
303
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
| – | – |
-110
| Closed | -$7K |
|
304
Mistras Group
MG
$484M
| – | – |
-26,000
| Closed | -$592K |
|
|
305
PVH
PVH
$4B
| – | – |
-5,558
| Closed | -$693K |
|
|
MNTA
306
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-290
| Closed | -$6K |
|
|
CYNO
307
DELISTED
Cynosure, Inc. Class A
CYNO
| – | – |
-23,000
| Closed | -$674K |
|
|
TEUM
308
DELISTED
Pareteum Corporation
TEUM
| – | – |
0
| – | – |
|
|
ACI
309
DELISTED
ARCH COAL, INC.
ACI
| $0 | ﹤0.01% |
7
| – | – |
|
|
INP
310
DELISTED
iPath ETNs Linked to the MSCI India Total Return Index
INP
| – | – |
-200
| Closed | -$12K |
|
Similar funds
AJ
MWS
LHR
HPFG
GWM
KC
SL
CSWM
AlphaMark Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, AlphaMark Advisors held 314 positions worth $168M, up 3.3% from $162M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
AlphaMark Advisors's Q2 2014 filing shows 29 new, 45 increased, 71 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 46,823 shares worth $3.88M. The largest sale was Perrigo, an estimated $3.81M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
- AlphaMark Advisors's largest Q2 2014 buy was Gilead Sciences: 46,823 shares worth $3.88M.
- AlphaMark Advisors added most to Momenta Pharmaceuticals, Inc. in Q2 2014, an estimated $788K increase.
- AlphaMark Advisors's biggest Q2 2014 reduction was Perrigo, cutting an estimated $3.81M.
- AlphaMark Advisors fully exited Vaalco Energy in Q2 2014, selling an estimated $945K.
- AlphaMark Advisors's ten largest holdings make up 28% of its $168M portfolio in Q2 2014.
- AlphaMark Advisors opened 29 new positions and closed 9 in Q2 2014.
- AlphaMark Advisors's portfolio value rose 3.3% quarter-over-quarter to $168M.
Based on AlphaMark Advisors's 13F filing for Q2 2014, filed 29 Jul 2014.